Pulse Biosciences Inc Sustainability Reports
Pulse Biosciences, Inc. is a bioelectric medicine company developing a novel and proprietary platform technology called Nanosecond Pulsed Field Ablation (nsPFA). The technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 529900NJUBI06118FM73
FIGI: BBG00BRBHVG7
5 reports from 2016 to 2024